BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for the ...
Laboratory Corporation of America Holdings (LabCorp) is the first national clinical laboratory to offer HCV PCR testing using a newly FDA approved assay, the Roche COBAS AmpliPrep/COBAS TaqMan HCV ...
According to a new study presented at The Liver Meeting, combining universal screening for the hepatitis C virus (HCV) with reflex RNA PCR in pregnant women is more cost-effective than risk-based ...
Chronic hepatitis C infection affects an estimated 50 million people globally, causes approximately 242,000 deaths per year mostly due to cirrhosis and liver cancer Same-day results will help ...
This faster polymerase chain test (PCR) allows same-day diagnosis and prompt treatment for the people affected with liver disease. This expeditious assessment aims to prevent costly and ruinous ...
To develop the new rapid polymerase chain reaction (PCR) test for HCV, the scientists used the DASH® (Diagnostic Analyzer for Specific Hybridization)PCR platform, which was originally developed at ...
Hearts and lungs from donors with hepatitis C viremia are typically not transplanted. The advent of direct-acting antiviral agents to treat hepatitis C virus (HCV) infection has raised the possibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results